Chemometrically assisted differential pulse voltammetry for simultaneous and interference-free quantification of gallic and caffeic acids.

This article explores the application of chemometric tools including multivariate curve resolution with alternating least squares for the simultaneous determination of gallic and caffeic acids on the surface of a glassy carbon electrode without additional modification. Gallic and caffeic acids are primary polyphenols, the most abundant in red wines produced in Argentina, and are often used as quality markers for them. These polyphenols significantly contribute to the organoleptic properties of wines from this origin, but their electrochemical signals overlap significantly, making simultaneous quantification challenging without additional experiments such as electrode modification or alternative analytical techniques beyond differential pulse voltammetry. This study successfully quantified these compounds in complex mixtures by generating second-order data from differential pulse voltammetry experiments conducted at various potential steps and subsequently applying multivariate curve resolution with alternating least squares. The use of constraints during optimization prevented rotational ambiguities common in this modeling, leading to unique results in validation samples. The limits of detection (LOD) found for gallic and caffeic acids were 1.6 and 7.6 mg L-1, which are in excellent agreement with the expected concentrations of these compounds in red wines. The concentration ranges analyzed showed a linear dependency (between the LOD and 300 mg L-1) with the signals estimated by the model for both analytes. Advantages such as simplicity, low cost, and high speed, as well as not requiring electrode modification, combined with excellent results obtained for real samples, make it a promising alternative for polyphenol analysis in the wine industry.

Angiotensin II involvement in the development and persistence of amphetamine-induced sensitization: Striatal dopamine reuptake implications.

Amphetamine (AMPH) exposure induces behavioural and neurochemical sensitization observed in rodents as hyperlocomotion and increased dopamine release in response to a subsequent dose. Brain Angiotensin II modulates dopaminergic neurotransmission through its AT1 receptors (AT1-R), positively regulating striatal dopamine synthesis and release. This work aims to evaluate the AT1-R role in the development and maintenance of AMPH-induced sensitization. Also, the AT1-R involvement in striatal dopamine reuptake was analysed. The sensitization protocol consisted of daily AMPH administration for 5 days and tested 21 days after withdrawal. An AT1-R antagonist, candesartan, was administered before or after AMPH exposure to evaluate the participation of AT1-R in the development and maintenance of sensitization, respectively. Sensitization was evaluated by locomotor activity and c-Fos immunostaining. Changes in dopamine reuptake kinetics were evaluated 1 day after AT1-R blockade withdrawal treatment, with or without the addition of AMPH in vitro. The social interaction test was performed as another behavioural output. Repeated AMPH exposure induced behavioural and neurochemical sensitization, which was prevented and reversed by candesartan. The AT1-R blockade increased the dopamine reuptake kinetics. Neither the AMPH administration nor the AT1-R blockade altered the performance of social interaction. Our results highlight the AT1-R's crucial role in AMPH sensitization. The enhancement of dopamine reuptake kinetics induced by the AT1-R blockade might attenuate the neuroadaptive changes that lead to AMPH sensitization and its self-perpetuation. Therefore, AT1-R is a prominent candidate as a target for pharmacological treatment of pathologies related to dopamine imbalance, including drug addiction and schizophrenia.

New trends in the development of electrochemical biosensors for the quantification of microRNAs.

MicroRNAs (miRNAs) are non-coding regulatory RNAs that play an important role in RNA silencing and post-transcriptional gene expression regulation. Since their dysregulation has been associated with Alzheimer disease, cardiovascular diseases and different types of cancer, among others, miRNAs can be used as biomarkers for early diagnosis and prognosis of these diseases. The methods commonly used to quantify miRNAs are, in general, complex, costly, with limited application for point-of-care devices or resource-limited facilities. Electrochemical biosensors, mainly those based on nanomaterials, have emerged as a promising alternative to the conventional miRNA detection methods and have paved the way to the development of sensitive, fast, and low-cost detection systems. This review is focused on the most relevant contributions performed in the field of electrochemical miRNAs biosensors between 2017 and the beginning of 2020. The main contribution of this article is the critical discussion of the different amplification strategies and the comparative analysis between amplified and non-amplified miRNA electrochemical biosensing and between the different amplification schemes. Particular emphasis was given to the importance of the nanostructures, enzymes, labelling molecules, and special sequences of nucleic acids or analogues on the organization of the different bioanalytical platforms, the transduction of the hybridization event and the generation the analytical signal.